The store will not work correctly when cookies are disabled.
1-(2-Deoxy-2-fluoro-beta-D-ribofuranosyl)tetrahydro-2(1H)-pyrimidinone
ID: ALA3237554
PubChem CID: 57704512
Max Phase: Preclinical
Molecular Formula: C9H15FN2O4
Molecular Weight: 234.23
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NCCCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1F
Standard InChI: InChI=1S/C9H15FN2O4/c10-6-7(14)5(4-13)16-8(6)12-3-1-2-11-9(12)15/h5-8,13-14H,1-4H2,(H,11,15)/t5-,6-,7-,8-/m1/s1
Standard InChI Key: DINLEAHFNSLTEA-WCTZXXKLSA-N
Molfile:
RDKit 2D
16 17 0 0 0 0 0 0 0 0999 V2000
12.4113 -21.1904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8935 -20.5316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7187 -20.5316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6497 -19.7450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9662 -19.7249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3209 -19.2547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8657 -19.4894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8454 -18.6717 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7541 -19.4685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4646 -19.8842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1884 -19.4720 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1895 -18.6465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4747 -18.2315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7591 -18.6420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2056 -21.1941 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.4667 -20.7049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 1 0
3 5 1 0
4 6 1 0
5 6 1 0
2 1 1 6
7 8 1 0
4 7 1 1
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
5 9 1 1
3 15 1 6
10 16 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 234.23 | Molecular Weight (Monoisotopic): 234.1016 | AlogP: -1.18 | #Rotatable Bonds: 2 |
Polar Surface Area: 82.03 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.66 | CX Basic pKa: ┄ | CX LogP: -1.70 | CX LogD: -1.70 |
Aromatic Rings: ┄ | Heavy Atoms: 16 | QED Weighted: 0.56 | Np Likeness Score: 1.08 |
References
1. Ferraris D, Duvall B, Delahanty G, Mistry B, Alt J, Rojas C, Rowbottom C, Sanders K, Schuck E, Huang KC, Redkar S, Slusher BB, Tsukamoto T.. (2014) Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase., 57 (6): [PMID:24520856] [10.1021/jm401856k] |